1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Reporter Account

Kollodis BioSciences, Inc. Enters Into Japanese Distribution Agreement With Funakoshi Co., Ltd.

Mussel adhesive protein based coatings that modify plastic surfaces and membranes in order to promote cell attachment and monolayer formation are now available in Japan

FOR IMMEDIATE RELEASE

PRLog (Press Release) - Oct 14, 2009 -
Kollodis BioSciences, Inc. announced today that it has entered into a Distribution Agreement with Funakoshi Co., Ltd. for the distribution of Kollodis BioSciences, Inc.'s MAPTrix® ECM line of products for cell culture and related applications. The non-exclusive agreement provides Funakoshi with the rights to distribute Kollodis’ cell culture products in Japan.

Dr. Louis M. Scarmoutzos, President & CEO of Kollodis BioSciences, Inc., stated, "We are absolutely delighted with this distribution agreement. Funakoshi is a well-established and highly reputable partner for bringing Kollodis' research products to the Japanese market. They have an excellent reputation with their customers and suppliers. We look forward to a lasting and fruitful relationship with Funakoshi."

Among the Mussel Adhesive Protein based matrix (MAPTrix®) ECM line of products are reagents with genetically incorporated bioactive peptides (recognition peptides) that mimic the extracellular matrix (ECM) activity of collagen, fibronectin, laminin, and vitronectin proteins. The bioactive peptide mimics the extracellular matrix (ECM) protein and provides for cell attachment, spreading and growth. The mussel adhesive protein confers biocompatible adhesion to a wide variety of surfaces.


About Funakoshi Co., Ltd.

Funakoshi Co., Ltd. is a leading Japanese distributor of biotech reagents and instrumentation for researchers in the life sciences and related fields. Funakoshi offers leading edge products and technologies for Japanese researchers from all over the world. For more information, visit Funakoshi's website at www.funakoshi.co.jp.

Kollodis BioSciences, Inc.

Kollodis BioSciences, Inc. has successfully developed a proprietary recombinant protein expression system for the large scale production of various mussel adhesive proteins (MAP). Kollodis is developing MAP-based smart biomaterials for biotech, medical and industrial applications. The Company's proprietary and patented MAPTrix® platform technology recombinantly incorporates bioactive peptides into a mussel adhesive protein (MAP) for cell culture and related applications. Additional information is available on the Company's website at www.kollodis.com.

# # #

Kollodis BioSciences, Inc. is focused on the ongoing development of our proprietary mussel adhesive protein material based solutions that are clinically proven, and add value to our customer's products.

For this goal, Kollodis continues to be committed to providing our customers with products of the highest quality which also comply with all applicable regulatory requirements such as the ISO 9001:2000.

Kollodis also continues to offer a wide range of biofunctional materials using its proprietary technology, MAPTrix™, to provide superior and innovative mussel adhesive protein based biomaterials as well as support its products.

--- end ---

Click to Share

Contact Email:
***@kollodis.com Email Verified
Source:Kollodis BioSciences, Inc.
Phone:1.617.283.2182
Fax:1.801.760.0659
Address:36 Dartmouth Street, Suite 304
Zip:02148
City/Town:Malden
State/Province:Massachusetts
Country:United States
Industry:Biotech, Research, Marketing
Tags:, , serum-free stem cell culture, extracellular matrix mimic, antimicrobial coating
Last Updated:Oct 14, 2009
Shortcut:http://prlog.org/10375920
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
3.5K1.4K1.3K
Click to Share